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A spectroﬂuorimetric method is proposed for the determination of human serum albumin (HSA) and bovine serum albumin
(BSA) using terbium-danoﬂoxacin (Tb3+-Dano) as a ﬂuorescent probe. These proteins remarkably enhance the ﬂuorescence
intensity of the Tb3+-Dano complex at 545nm, and the enhanced ﬂuorescence intensity of Tb3+-Dano is proportional to the
concentration of proteins (HSA and BSA). Optimum conditions for the determination of HSA were investigated and found that
the maximum response was observed at: pH = 7.8, [Tb3+] = 8.5 × 10
−5 mol L−1, [Dano] = 1.5 × 10
−4 mol L−1. The calibration
graphs for standard solutions of BSA, HSA, and plasma samples of HSA were linear in the range of 0.2 × 10
−6 − 1.3 × 10
−6 mol
L−1,0 .2×10
−6 −1.4×10
−6 mol L−1, and 0.2×10
−6 −1×10
−6 mol L−1, respectively. The detection limits (S/N = 3) for BSA, HSA,
and plasma sample of HSA were 8.7 × 10
−8 mol L−1,6 .2 × 10
−8 mol L−1, and 8.1 × 10
−8 mol L−1, respectively. The applicability of
the method was checked using a number of real biological plasma samples and was compared with the UV spectrometric reference
method. The results was showed that the method could be regarded as a simple, practical, and sensitive alternative method for
determination of albumin in biological samples.
1.Introduction
The development of novel methods and new techniques for
proteindeterminationisveryimportantinanumberofareas
suchaschemicalandbiochemicalanalyses,immunodiagnos-
tics, and biotechnology. There is a connection between the
contentofhumanserumalbumin(HSA)inplasmaandsome
diseases, such as kidney [1] or chronic liver diseases [2]a n d
unstable angina [3] in addition the enhancement of albumin
in cerebrospinal ﬂuid (CSF) samples of amyotrophic lateral
sclerosis (ALS) patients was reported [4–7]. Application of
albumin level in body ﬂuids as a biomarker of these diseases
has been suggested, and development of simple and precise
methods which could be applicable in routine bioanalytical
methods is needed.
According to the above-mentioned facts, determination
of HSA is an important issue in clinical diagnosis. Unfortu-
nately, the traditional methods for the determination of pro-
teins have some disadvantages. For example, Lowry [8] assay
can be used only for protein concentration >10mgmL−1.
Bradford [9] assay has the drawback of contaminating ves-
sels. The silver staining method [10] is complicated as
multiplestepsareinvolved.Sothechemiluminescentanalysis
[11], ﬂuorimetric analysis, and resonance light scattering
[12–14] methods have been proposed due to their high
sensitivityandselectivity.Amongthem,ﬂuorescencemethod
stands out since its obvious sensitivity is some orders of
magnitude higher than that of other spectral detections,
especially when the method was incorporated into high-
performance liquid chromatography (HPLC) and capillary
electrophoresis (CE) [15]. It is well known that only proteins
possessing phenylalanine, or tryptophan, or a combination
there of, exhibit natural ﬂuorescence. But the resulted
emission is too weak to be applied for the analysis of proteins
(e.g., albumin) at low concentration. In order to solve this
problem, protein can be converted into suitable derivatives
by chemical derivatization, typically using a derivatization
reaction or spectral probes. There are many publications2 The Scientiﬁc World Journal
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Figure 1: Excitation and emission spectra. (a): Excitation spectra (b): Emission spectra. (1) Tb3+, (2) BSA, (3) HSA, (4) Tb3+-BSA, (5)
Tb3+-HSA, (6) Tb3+-Dano, (7) Tb3+-Dano-BSA, (8) Tb3+-Dano-HSA, (9) Tb3+-Dano-HSA (plasma sample). Analytical conditions: [Tb3+]
= 8.5 × 10−5 mol L−1, [Dano] =1.5 × 10−4 molL−1,[ B S A ]= 1 × 10−6 mol L−1,[ H S A ]= 1 × 10−6 molL−1, [HSA in plasma sample] = 1 ×
10−6 molL−1,p H= 7.8, λex/λem = 347nm/545nm.
Table 1: Eﬀect of the addition order of reagents on the enhanced ﬂuorescence intensity (ΔF%).
Reagent Reagent Reagent Reagent ΔF%
Tb3+ Dano Albumin Buﬀer 46.6
Tb3+ Dano Buﬀer Albumin 37.5
Tb3+ Buﬀer Dano Albumin 30.9
Tb3+ Buﬀer Albumin Dano 36.9
Tb3+ Albumin Dano Buﬀer 34.7
Tb3+ Albumin Buﬀer Dano 43.5
Dano Tb3+ Albumin Buﬀer 39.5
Dano Tb3+ Buﬀer Albumin 41.7
Dano Buﬀer Tb3+ Albumin 37.3
Dano Buﬀer Albumin Tb3+ 44.2
Dano Albumin Buﬀer Tb3+ 43.0
Dano Albumin Tb3+ Buﬀer 41.3
Buﬀer Tb3+ Dano Albumin 26.5
Buﬀer Tb3+ Albumin Dano 24.5
Buﬀer Albumin Dano Tb3+ 40.7
Buﬀer Albumin Tb3+ Dano 33.6
Buﬀer Dano Albumin Tb3+ 41.7
Buﬀer Dano Tb3+ Albumin 40.1
Albumin Tb3+ Dano Buﬀer 37.6
Albumin Tb3+ Buﬀer Dano 40.1
Albumin Dano Buﬀer Tb3+ 39.5
Albumin Dano Tb3+ Buﬀer 43.1
Albumin Buﬀer Tb3+ Dano 31.9
Albumin Buﬀer Dano Tb3+ 25.8
Analytical conditions: [Tb3+]: 8.5 × 10−5 molL−1; [Dano]: 1.5 × 10−4 molL−1;[ H S A ] :1× 10−6 molL−1;p H= 7.8.
reporting the use of derivatization methods for improving
proteins detectability [16–18]. Up to now, a number of
ﬂuorescence methods for the determination of proteins have
been established based on extrinsic ﬂuorescence probe such
as rare earth ions and complexes, or dyes [19–24]. In this
work, for the ﬁrst time, we employ the ﬂuorescence of
terbium-danoﬂoxacin (Tb3+-Dano) complex as a probe for
the determination of albumin. The proposed method was
applied to the determination of HSA in human plasma
samples and the results were in good agreement with theThe Scientiﬁc World Journal 3
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Figure 2: Eﬀect of pH on the enhanced ﬂuorescence intensity
(ΔF%) analytical conditions: [Tb3+]: 1 × 10−4 molL−1; [Dano]: 1
× 10−4 molL−1; [HSA]: 1 × 10−6 molL−1.
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Figure 3: Eﬀect of concentration of Tris buﬀer on the enhanced
ﬂuorescence intensity (ΔF%) analytical conditions: [Tb3+]: 1 ×
10−4 molL−1; [Dano]: 1 × 10−4 molL−1; [HSA]: 1 × 10−6 molL−1;
pH = 7.8.
results obtained by the standard UV-Vis spectrophotometer
method [25].
2. Experimental
2.1. Materials and Methods. Analytical-grade ethanol, hy-
drochloric acid (HCl), methanol, 2-propanol, acetonitrile,
and tris-(hydroxymethyl) aminomethane (Tris) were ob-
tained from Merck (Darmstadt, Germany), terbium(III)
chloride hexahydrate (TbCl3·6H2O) from Acros Organics
(Geel,Belgium),DanopowderfromJamedatAfaghPharma-
ceutical Company (Tehran, Iran), proteins (HSA and BSA)
standardsolution(1 ×10−4 gdL −1),andspectrophotometric
detection kit from Pars Analysis company (Tehran, Iran).
Double-distilled water prepared using the Millipore-Q-plus
water puriﬁcation system (Millipore, Bedford, MA, USA)
was used in this study.
A1.0×10−2 molL−1 terbium(III)solutionwasprepared
by dissolving the appropriate amount of TbCl3·6H2Oi n
double-distilled water and stored in a polyethylene container
toavoidmemoryeﬀectsofterbiumadsorbedonglassvessels.
As t o c ks o l u t i o n( 1 . 0× 10−2 molL−1) of Dano was prepared
in double-distilled water, and 0.1molL−1 Tris-hydrochloric
acid (Tris-HCl) buﬀer solution was prepared by dissolving
thedesiredamountofTris-basein100mLofwater,adjusting
the pH to 7.8 with HCl.
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Figure 4: Eﬀect of the Tb3+concentration on the enhanced ﬂu-
orescence intensity (ΔF%)analytical conditions: [Dano]: 1 ×
10−4 molL−1; [HSA]: 1 × 10−6 molL−1;p H= 7.8.
2.2. Apparatus. Fluorescence spectra and intensity measure-
ments were performed on a Jasco FP-750 spectroﬂuorimeter
(Kyoto, Japan) equipped with a 150W xenon lamp, using
a 10mm quartz cell 5nm. The excitation wavelength was
set at 347nm, and the ﬂuorescence intensity was measured
at 545nm. All measurements were performed at 25◦C,
controlled using a Peltier thermostated cell holder (Jasco,
Japan). The pH of solutions was measured with Metrohm
654 pH meter (Herisau, Switzerland).
UV-Vis spectrophotometer (Beckman DU-650, Fuller-
ton) was used for determination of albumin by a detection
kit.
2.3. Sample Preparation
2.3.1. Standard Sample. The working solutions of HSA
and BSA (1 × 10−5 molL−1) were obtained by appropriate
dilutions of the standard solutions (1 × 10−4 gdL −1)w i t h
double-distilled water. A 8.5 × 10−4 molL−1 of terbium
solution and 1.5 × 10−3 molL−1 of Dano solution were
prepared from the stock solutions.
2.3.2. Plasma Sample Preparation. The developed method
was applied to the determination and quantiﬁcation of HSA
inplasmasamples.Asthemainproportionofplasmaprotein
content is albumin (about 60%) [26], the resulted intensities
can be regarded due to the albumin content of plasma rather
than other rare proteins. For the assay of HSA, the samples
must be diluted appropriately within the linear range of the
determination of HSA.
2.4. Experimental Procedure
2.4.1. Fluorescence Assay. For the analysis of albumin (HSA
a n dB S A )i nd i ﬀerent samples, solutions were added in the
following order: 1mL of 8.5 × 10−4 molL−1 Tb3+ solution,
1mLof1.5× 10−3 molL−1 Dano solution, suitable aliquots
of protein solution, and 0.4mL buﬀer 0.1molL−1 (pH =
7.8) into 10mL calibrated ﬂasks. The mixture was diluted up
to 10mL with double-distilled water and allowed to stand
for 5min at room temperature. The ﬂuorescence intensity
was measured at λex/λem = 347nm/545nm. The enhanced4 The Scientiﬁc World Journal
Table 2: Interference eﬀect on the enhanced ﬂuorescence intensity(ΔF%).
Interfere substance Concentration of interfere
substance (×10−3 molL−1)
Tolerance ratio
(species/HSA) Chang of ΔIF%
Na+(Cl−) 5 5000 1.3
Fe3+ (Cl−) 0.005 5 −4.2
K+ (CL−) 3 3000 −2.3
NH4
+ (Cl−) 4.2 4200 −4.7
Saccharose 1 1000 3.7
Glycine 1 1000 −2.4
Mn2+ (Cl−)0 . 0 5 5 0 −3.8
ctDNA 0.00075 0.75 3.0
Al3+ (Cl−) 0.005 5 −4.9
Ba2+ (Cl−) 1.4 1400 −3.4
Ca2+ (Cl−) 1.15 1150 −4.2
Na+ (CO3
2−) 1.19 1900 −3.7
Analytical conditions: [Tb3+]: 8.5 × 10−5 molL−1; [Dano]: 1.5 × 10−4 molL−1;[ H S A ] :1× 10−6 molL−1;p H= 7.8.
Table 3: Validation data of the proposed method for quantiﬁcation of BSA, HSA, and HSA in human plasma.
Parameters BSA HSA HSA in plasma
Linear range (mol L−1)0 . 2 × 10−6–1.3 × 10−6 0.2 × 10−6–1.4 × 10−6 0.2 × 10−6–1 × 10−6
Slope 32.775 42.574 217.130
Intercept 3.9446 0.2742 −14.6410
Correlation coeﬃcient 0.9991 0.9990 0.9899
Number of data points 12 13 9
LOD (mol L−1)8 . 7 × 10−8 6.2 × 10−8 8.1 × 10−8
ﬂuorescence intensity of Tb3+-Dano by HSA was represented
asΔF% =100(F −F0)/F0 whereFandF0 aretheﬂuorescence
intensities of the systems with HSA and without HSA,
respectively.
2.4.2. Standard UV-Vis Spectrophotometry Assay. For the
analysis of HSA by standard UV spectrophotometry the
following procedure was used: to preparation of blank,
standard, and sample solutions, 10μL double-distilled water,
10μL standard solution, and 10μL sample were added into
2mL micro tubes containing 1mL reagents, respectively.
After complete mixing, the solution should be incubated
for 10min in 37◦C. The absorbance of the standard and
sample solution should be measured against blank solution
at λ = 546nm in 60min. the concentration is calculated
using following formula:
Albumin

molL
−1

=
Sample Absorbance ×Standard Concentration

mol L
−1

Standard Absorbance
. (1)
3. Results andDiscussion
3.1. Fluorescence Spectra. Fluorescence emission and excita-
tionspectraofTb3+,BSA,HSA,Tb 3+-BSA,Tb3+-HSA,Tb3+-
Dano, Tb3+-Dano-BSA, Tb3+-Dano-HSA, and Tb3+-Dano-
HSA (plasma sample) are shown in Figure 1.T b 3+ solution
does not show the characteristic ﬂuorescence spectrum,
while by adding Dano to Tb3+ solution, intense ﬂuorescence
was observed. The maximal excitation wavelength of Tb3+-
Dano occurs at 347nm and two emission peaks at 490
and 545nm, corresponding to the 5D4-7F6 transition and
5D4-7F5 transition of Tb3+,r e s p e c t i v e l y .T h eﬂ u o r e s c e n c e
intensity at 545nm is the greatest. Therefore, the excitation
and emission peaks were set at 347 and 545nm, respectively.
The ﬂuorescence spectrum of the Tb3+-Dano-HSA system
was similar to that of Tb3+-Dano; however, the ﬂuorescence
intensity of Tb3+-Dano was enhanced by proteins (HSA and
BSA), and the complementary experiments showed that the
enhancement was proportional to the concentration of the
proteins.The Scientiﬁc World Journal 5
Table 4: Intra-assay precision and accuracy of calibration standards.
Analyte name Nominal concentration
(mol L−1)( N = 3)
Found concentration
(molL−1)( N = 3) Precision (RSD%) Accuracy (RE %)
BSA
0.3 × 10−6 0.286 × 10−6 2.78 −4.5
0.5 × 10−6 0.489 × 10−6 3.91 −2.2
0.7 × 10−6 0.714 × 10−6 3.97 1.9
1.0 × 10−6 0.992 × 10−6 0.50 −0.8
1.2 × 10−6 1.194 × 10−6 2.78 −0.5
HSA
0.3 × 10−6 0.308 × 10−6 2.85 2.9
0.5 × 10−6 0.510 × 10−6 3.19 2.1
0.7 × 10−6 0.713 × 10−6 3.14 1.9
1.0 × 10−6 0.994 × 10−6 1.53 −0.5
1.2 × 10−6 1.185 × 10−6 1.44 −1.2
HSA in
plasma
0.3 × 10−6 0.277 × 10−6 4.13 −7.6
0.5 × 10−6 0.519 × 10−6 3.94 3.7
0.7 × 10−6 0.711 × 10−6 5.08 1.6
0.8 × 10−6 0.791 × 10−6 4.23 −1.0
1.0 × 10−6 0.959 × 10−6 3.58 −4.1
Table 5: Assay precision and accuracy of quality control samples.
Analyte name Concentration
(mol L−1)
Intra-assay precision
(RSD%)
Inter-assay precision
(RSD%) Accuracy (RE%)
BSA
0.3 × 10−6 2.62 4.55 −3.9
0.7 × 10−6 4.39 1.70 1.1
1.2 × 10−6 4.70 3.57 2.6
HSA
0.3 × 10−6 3.19 4.07 4.4
0.7 × 10−6 2.79 4.62 3.1
1.2 × 10−6 2.00 2.60 −0.4
HSA in
plasma
0.3 × 10−6 6.44 8.08 −6.3
0.5 × 10−6 4.16 4.90 1.5
0.8 × 10−6 3.85 3.58 −2.7
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Figure 5: Eﬀect of the amount of Dano on the enhanced
ﬂuorescence intensity (ΔF%) analytical conditions: [Tb3+]: 8.5 ×
10−5 molL−1; [HSA]: 1 × 10−6 molL−1;p H= 7.8.
3.2. Optimization of Experimental Conditions
3.2.1. Eﬀect of pH. Fluorescence intensities of series of
0.1molL−1 Tris-HCl buﬀer solutions with the pH range
of 7.4–8.6 were measured at λex/λem = 347nm/545nm
(Figure 2). The enhancement intensity (ΔF%) of Tb3+-Dano
complexwithalbumin(HSAandBSA)isstronglydependent
on pH and reaches to maximum value at pH 7.8. Thus, pH
7.8 (0.1molL−1 Tris buﬀer) was selected as optimum pH for
the rest of analysis. Below this pH, the hydroxyl groups of
Dano are probably in protonated form, which disfavors the
complex formation. Also, Tb3+ ion would be precipitated in
the strong alkaline medium, which blocked the coordination
between the Dano and Tb3+ ion.
3.2.2. Eﬀect of Concentration of Tris Buﬀer. Tris buﬀer is
known to have chelating properties with lanthanide ions.
Hence, it is necessary to optimize its concentration that
will aﬀord maximum sensitization of the Tb3+-Dano-HSA
system. The inﬂuence of Tris buﬀer concentrations on
luminescence intensity of Tb3+ was studied (Figure 3)b y
varying the buﬀer volume of the buﬀer in the range of
0.1–3.0mL of 0.1molL−1 buﬀer solution while the concen-
trations of Tb3+, Dano, and HSA were 1 × 10−4 molL−1,6 The Scientiﬁc World Journal
Table 6: Absolute and mean recoveries for the studied analytes.
Analyte name Nominal concentration
(mol L−1)( N = 5)
Found concentration
(mol L−1)( N = 5) Recovery % Mean recovery % Precision of recovery
(RE%)
BSA
0.3 × 10−6 0.297 × 10−6 99 100.7 −1.0
0.7 × 10−6 0.698 × 10−6 99.7 −0.3
1.2 × 10−6 1.240 × 10−6 103.3 3.3
HSA
0.3 × 10−6 0.294 × 10−6 98 99.3 −2.0
0.7 × 10−6 0.705 × 10−6 100.7 0.70
1.2 × 10−6 1.190 × 10−6 99.2 −0.8
HSA in
plasma
0.3 × 10−6 0.283 × 10−6 94.3 95.9 −5.7
0.5 × 10−6 0.489 × 10−6 97.8 −2.2
0.8 × 10−6 0.765 × 10−6 95.6 −4.4
Table 7: Stability at refrigerator (4◦C) for three days.
Analyte
Concentration
(mol L−1)
After one day at 4◦C After two days at 4◦C After three days at 4◦C
Concentration
found (mol L−1)
Accuracy
(RE%)
Concentration
found (mol L−1)
Accuracy
(RE%)
Concentration
found (mol L−1)
Accuracy
(RE%)
BSA
0.3 × 10−6 0.224 × 10−6 −25.3 0.216 × 10−6 −28.1 0.210 × 10−6 −29.9
0.7 × 10−6 0.624 × 10−6 −10.8 0.606 × 10−6 −13.4 0.589 × 10−6 −15.7
1.2 × 10−6 1.019 × 10−6 −15 0.983 × 10−6 −18.1 0.962 × 10−6 −19.8
HSA
0.3 × 10−6 0.26 × 10−6 −14.1 0.251 × 10−6 −16.1 0.249 × 10−6 −16.8
0.7 × 10−6 0.583 × 10−6 −16.6 0.569 × 10−6 −18.7 0.565 × 10−6 −19.2
1.2 × 10−6 0.995 × 10−6 −17.1 0.982 × 10−6 −18.2 0.945 × 10−6 −21.2
HSA in plasma
0.3 × 10−6 0.217 × 10−6 −27.5 0.216 × 10−6 −27.9 0.214 × 10−6 −28.8
0.5 × 10−6 0.430 × 10−6 −13.9 0.421 × 10−6 −15.8 0.415 × 10−6 −16.9
0.8 × 10−6 0.649 × 10−6 −18.9 0.641 × 10−6 −19.8 0.637 × 10−6 −20.4
1 × 10−4 molL−1,a n d1× 10−6 molL−1,r e s p e c t i v e l y .T h e
coordination of Tb3+ ions by Tris prevents the OH groups
of water molecules from surrounding the terbium ions and
reduces the complexation of Dano. In lower concentrations
of Tris, the buﬀer could not coordinate terbium ions
completely, and the ﬂuorescence intensity is decreased. The
results indicated that the ﬂuorescence of the probe in the
presence of the analyte at buﬀer volumes between 0.3mL–
0.55mL is constant, therefore 0.4mL of 0.1molL−1 Tris
buﬀer was selected as optimum buﬀer content.
3.2.3. Eﬀect of Tb3+ Concentration. The eﬀect of the Tb3+
concentration on the luminescence intensity enhancement
(ΔF % )o fT b 3+-Dano-HSA system was studied (Figure 4), at
constant concentration of 1 × 10−6 molL−1 HSA. The ΔF%
was highest when the concentration of Tb3+ in the mixture
was in the rang of 8 × 10−5 molL−1–9 × 10−5 molL−1.
Intermediate Tb3+ concentration (8.5 × 10−5 molL−1)w a s
chosen for further analysis.
3.2.4. Eﬀect of the Dano Concentration. The inﬂuence of
the Dano concentration on the ﬂuorescence intensities was
studied (Figure 5), and it was found that the ﬂuorescence
intensity enhancement of Tb3+-Dano-HSA system reached
a maximum when the concentration of Dano was 1.5 ×
10−4 molL−1.S o1 . 5× 10−4 molL−1 w a su s e da so p t i m u m
concentration of Dano for further study.
3.2.5. Eﬀect of Reaction Time. Under the optimum condi-
tions, the eﬀect of reaction time on the ﬂuorescence intensity
was studied. It was found that the ﬂuorescence intensity is
stable for about 50min after addition of all reagents. This is
due to the rapid complex formation between Tb3+ and Dano
and HSA. In this study, 5min was set as the standard time
interval for all ﬂuorescence intensity measurements.
3.2.6. Eﬀect of Temperature. Temperature had signiﬁcant
inﬂuenceontheﬂuorescenceintensityofthesystem;atlower
temperatures the enhancement ﬂuorescence in the presence
of HSA was decreased, therefore we selected room tempera-
ture (25◦C )f o rf u r t h e rs t u d y .
3.2.7. Eﬀect of the Addition Order of Reagents. Series of
solutions were prepared with diﬀerent addition orders of
reagents but the same concentrations of reagents (F), and
their corresponding blank solutions (F0)w e r em e a s u r e da t
λex/λem = 347nm/545nm. The results showed that diﬀerent
orders of addition of components have signiﬁcant impact on
both F and ΔF% (Table 1). The highest enhancement in the
intensityoftheﬂuorescenceprobeinthepresenceofalbuminThe Scientiﬁc World Journal 7
Table 8: Determinations of HSA in diﬀerent plasma samples obtained from diﬀerent human blood samples.
Sample number The proposed method Standard UV spectrophotometry
Found concentration
(×10−4molL−1)( R S D % )( N = 3)
Found concentration
(×10−4molL−1)( R S D % )( N = 3)
1 6.93 6.78
(4.5) (1.2)
2 6.36 6.11
(3.4) (2.8)
3 6.46 6.20
(8.6) (3.9)
4 6.35 6.25
(4.1) (2.2)
5 6.40 6.26
(5.2) (2.4)
6 6.09 6.01
(9.4) (1.4)
7 6.87 6.69
(8.7) (2.1)
wasobtainedfortheadditionofreagentsintheorderofTb3+,
Dano, HSA, and buﬀer.
3.2.8. Surfactant Eﬀect. I no r d e rt oi m p r o v eﬂ u o r e s c e n c e
intensity various surfactants such as SDS, SDBS, CTAB,
Tween 20, Tween 80, Triton X-100, and Triton X-114 were
added to the solution, and their eﬀect was studied. None of
the studied surfactants had signiﬁcant eﬀect on ΔF%.
3.2.9. Solvent Eﬀect. The eﬀect of diﬀerent solvents on ﬂu-
orescence intensity was investigated at optimum conditions.
Although some solvents (e.g., methanol) improved the ΔF%,
they decreased the ﬂuorescenceintensities of the probe in the
presence or absence of HSA which can lead to the decreased
repeatability. In addition to the decreased repeatability and
the nontoxicity of water, it was chosen for further study
(Figure 6).
3.3. Interference Studies. The interference of various exoge-
nous substances was tested and shown in Table 2.I tw a s
found that except ctDNA, other substances had little eﬀect
on the determination of HSA: 1 × 10−6 molL−1 within the
acceptable error range (±5%).
3.4. Analytical Applications and Assay Validation
3.4.1. The Calibration Graphs and Detection Limits. Under
the optimum condition deﬁned, the calibration graphs for
albumin samples were obtained, and the results are shown
in Table 3. It can be seen that there is a linear relationship
between the ﬂuorescence intensity of the system and the
concentration of analytes in the range of 0.2 × 10−6–1.3 ×
10−6 molL−1 for BSA, 0.2 × 10−6–1.4 × 10−6 molL−1 for
HSA standard solutions, 0.2 × 10−6–1 × 10−6 mol L−1 for
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Figure 6: Solvent eﬀect on the enhanced ﬂuorescence intensity
(ΔF%)Analytical conditions: [Tb3+]: 8.5 × 10−5 molL−1;[ D a n o ] :
1.5 × 10−4 molL−1; [HSA]: 1 × 10−6 molL−1;p H= 7.8.
HSA in plasma samples. The detection limits (S/N = 3) for
BSA, HSA standard solutions, and plasma samples were 8.7
× 10−8 molL−1,6 . 2× 10−8 molL−1,a n d8 . 1× 10−8 molL−1,
respectively.
3.4.2. Precision and Accuracy. The results of intra-assay
precision and accuracy of calibration standards are shown
in Table 4. All relative standard deviation (RSD%) was
below 5% for standard samples and below 15% for plasma
samples which were acceptable for bioanalytical methods
according to FDA recommendations [27]. Inter- and intra-
assay precisions along with accuracy for quality control
samples are listed in Table 5. Similar results obtained for
these validation experiments showed that the developed
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3.4.3. Recovery. The recoveries for the investigated albumin
samples are summarized in Table 6. The mean recoveries for
BSA, HSA, and HSA in plasma were 100.7%, 99.3%, and
95.9%, respectively.
3.4.4. Stability. Under the optimum conditions proposed
stability of the probe was investigated. It was found that
the ﬂuorescence intensity is stable for about 50min at room
temperature (25◦C) after addition of all reagents. Stability at
refrigerator temperature (4◦C) for three days after addition
of all reagents was investigated. After one day decrease in
the concentration of analyte is highest but in the second and
third days the deviation is less than the ﬁrst day. The stability
results at refrigerator temperature (4◦C) are summarized in
Table 7.
3.4.5. Analysis of Plasma Samples. T h ec a l i b r a t i o nc u r v ei n
plasma was used for the determination of HSA in the human
plasma and compared with the UV spectrophotometric
method. The results are shown in Table 8. This method of
measuring protein is more sensitive compared with the rou-
tine method.
4. Conclusions
In this paper, a new ﬂuorimetric method for the determi-
nation of albumin is reported. Under optimum conditions,
the enhanced intensity of ﬂuorescence is in proportion to
the concentration of albumin. Compared with standard
spectrophotometric method, the developed method has
the advantages of the simplicity and fast processing, low
detection limits and wide linear range. So the proposed
method is applicable to the determination of albumin
in plasma samples in decreased or enhanced levels. The
developed method is applicable in bioanalytical laboratories
as routine albumin analysis method.
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